123 related articles for article (PubMed ID: 35309942)
41. Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer.
Zhang Z; Xu Z; Yan Y
Front Med (Lausanne); 2021; 8():793515. PubMed ID: 35096881
[No Abstract] [Full Text] [Related]
42. Development and validation of pyroptosis-related lncRNAs prediction model for bladder cancer.
Lia T; Shao Y; Regmi P; Li X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 35024796
[TBL] [Abstract][Full Text] [Related]
43. A novel immune-related lncRNA pair signature for prognostic prediction and immune response evaluation in gastric cancer: a bioinformatics and biological validation study.
Wang J; Wang B; Zhou B; Chen J; Qi J; Shi L; Yu S; Chen G; Kang M; Jin X; Wang L; Xu J; Zhu L; Chen J
Cancer Cell Int; 2022 Feb; 22(1):69. PubMed ID: 35144613
[TBL] [Abstract][Full Text] [Related]
44. A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer.
Zhang F; Wang X; Hu H; Yang Y; Wang J; Tang Y; Li D; Bai Y; Han P
Bioengineered; 2021 Dec; 12(1):3802-3823. PubMed ID: 34281486
[TBL] [Abstract][Full Text] [Related]
45. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer.
Zhang K; Ping L; Du T; Liang G; Huang Y; Li Z; Deng R; Tang J
Front Mol Biosci; 2021; 8():678877. PubMed ID: 34164433
[No Abstract] [Full Text] [Related]
46. N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy.
Zhang MM; Lin YL; Zeng WF; Li Y; Yang Y; Liu M; Ye YJ; Jiang KW; Wang S; Wang S
Front Genet; 2021; 12():790888. PubMed ID: 34976022
[TBL] [Abstract][Full Text] [Related]
47. Prognostic model based on six PD-1 expression and immune infiltration-associated genes predicts survival in breast cancer.
Junjun S; Yangyanqiu W; Jing Z; Jie P; Jian C; Yuefen P; Shuwen H
Breast Cancer; 2022 Jul; 29(4):666-676. PubMed ID: 35233733
[TBL] [Abstract][Full Text] [Related]
48. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
49. Comprehensive Analysis of Regulatory Factors and Immune-Associated Patterns to Decipher Common and
Li Y; Dong W; Zhang P; Zhang T; Ma L; Qu M; Ma X; Zhou X; He Q
Front Cell Dev Biol; 2021; 9():750897. PubMed ID: 34733851
[No Abstract] [Full Text] [Related]
50. Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research.
Bai Z; Xu F; Feng X; Wu Y; Lv J; Shi Y; Pei H
Bioengineered; 2022 Jan; 13(1):1717-1735. PubMed ID: 35000541
[TBL] [Abstract][Full Text] [Related]
51. Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma.
Li T; Liu H; Dong C; Lyu J
Front Pharmacol; 2022; 13():806995. PubMed ID: 35153782
[No Abstract] [Full Text] [Related]
52. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive Analysis of Necroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients With Colon Cancer.
Liu L; Huang L; Chen W; Zhang G; Li Y; Wu Y; Xiong J; Jie Z
Front Mol Biosci; 2022; 9():811269. PubMed ID: 35237659
[TBL] [Abstract][Full Text] [Related]
54. Pyroptosis Patterns Characterized by Distinct Tumor Microenvironment Infiltration Landscapes in Gastric Cancer.
Xiang R; Ge Y; Song W; Ren J; Kong C; Fu T
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680930
[TBL] [Abstract][Full Text] [Related]
55. The prognosis of bladder cancer is affected by fatty acid metabolism, inflammation, and hypoxia.
Xiao Y; Yang J; Yang M; Len J; Yu Y
Front Oncol; 2022; 12():916850. PubMed ID: 36479065
[TBL] [Abstract][Full Text] [Related]
56. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
57. A Novel Pyroptosis-Related Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Osteosarcoma.
Zhang Y; He R; Lei X; Mao L; Jiang P; Ni C; Yin Z; Zhong X; Chen C; Zheng Q; Li D
Front Genet; 2021; 12():780780. PubMed ID: 34899864
[TBL] [Abstract][Full Text] [Related]
58. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
[TBL] [Abstract][Full Text] [Related]
59. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
Tang W; Xu F; Zhao M; Zhang S
BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
[TBL] [Abstract][Full Text] [Related]
60. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]